Offer - Urjas Oil for just ₹ 1
Nadibact Plus Cream 7.5gm is a prescription medicine that is available as a Cream. Nadibact Plus Cream 7.5gm also has some secondary and off-label uses. These are listed below.
The correct dosage of Nadibact Plus Cream 7.5gm depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Nadibact Plus Cream 7.5gm include Chills, Abdominal cramp, Abdominal Pain. Besides the aforementioned side effects, there are other adverse effects of Nadibact Plus Cream 7.5gm as well, which are listed below. Normally, these side effects of Nadibact Plus Cream 7.5gm are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Nadibact Plus Cream 7.5gm is Unknown for pregnant women and Unknown for women who are breastfeeding. It is important to know if Nadibact Plus Cream 7.5gm has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nadibact Plus Cream 7.5gm related warnings section.
Some other conditions that can be affected by Nadibact Plus Cream 7.5gm are listed in the contraindications section below.
Drug reaction of Nadibact Plus Cream 7.5gm with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Nadibact Plus Cream 7.5gm is safe while driving, and is addiction.
Nadibact Plus Cream 7.5gm is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Nadibact Plus Cream 7.5gm safe for pregnant women?
The effects of Nadibact Plus on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Nadibact Plus Cream 7.5gm safe during breastfeeding?
No research work has been carried out till date on effect of Nadibact Plus on breastfeeding women. So it is not known whether taking Nadibact Plus will cause side effects or not.
What is the effect of Nadibact Plus Cream 7.5gm on the Kidneys?
Nadibact Plus has very mild side effects on the kidneys.
What is the effect of Nadibact Plus Cream 7.5gm on the Liver?
Using Nadibact Plus does not have any harmful effects on the liver.
What is the effect of Nadibact Plus Cream 7.5gm on the Heart?
There may be an adverse effect on the heart after taking Nadibact Plus. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
If you are suffering from any of the following diseases, you should not take Nadibact Plus Cream 7.5gm unless your doctor advises you to do so -
Is this Nadibact Plus Cream 7.5gm habit forming or addictive?
Nadibact Plus Cream 7.5gm does not cause addiction.
Interaction between Food and Nadibact Plus Cream 7.5gm
Information is not available on the interaction of any foods with Nadibact Plus Cream 7.5gm, due to a lack of research on this.
Interaction between Alcohol and Nadibact Plus Cream 7.5gm
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Nadibact Plus Cream 7.5gm.
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vusion® (miconazole nitrate, zinc oxide, and white petrolatum)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elocon® (mometasone furoate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nasonex® (mometasone furoate monohydrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Asmanex® Twisthaler® (mometasone furoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 894
